SOPHiA GENETICS SA — Form 6-K Summary
Business context and reporting period
SOPHiA GENETICS SA, a Swiss foreign private issuer, filed a Form 6-K covering the month of June 2022. The filing was submitted on June 15, 2022, under Commission File Number 001-40627. The company indicates that it files annual reports on Form 20-F.
Financial metrics
The provided filing text contains no financial statements or clear values for revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material changes versus the prior comparable period
The filing text does not provide information describing material changes versus a prior comparable period.
Guidance, outlook, risks, and unusual items
The filing identifies two exhibits: a press release dated June 15, 2022, and an ESG Impact Summary dated June 2022. The contents of those exhibits are not included in the provided filing text, so no guidance, outlook, management commentary, risks, contingencies, or unusual items can be assessed.
Facts investors should verify
- Review Exhibit 99.1 for the company’s June 15, 2022 press release and any operating or financial updates.
- Review Exhibit 99.2 for the June 2022 ESG Impact Summary.
- Confirm any reported revenue, profitability, cash flow, liquidity, debt, guidance, and risk disclosures in the underlying exhibits or the company’s Form 20-F.